Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1CU CHEMIE UETIKON GMBH
01 1Thiamazole
01 1France
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Registration Number : 218MF10296
Registrant's Address : Raiffeisenstrasse 4, D-77933 Lahr Germany
Initial Date of Registration : 2006-02-28
Latest Date of Registration : 2023-07-05
A Thiamazol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Thiamazol, including repackagers and relabelers. The FDA regulates Thiamazol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Thiamazol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Thiamazol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Thiamazol supplier is an individual or a company that provides Thiamazol active pharmaceutical ingredient (API) or Thiamazol finished formulations upon request. The Thiamazol suppliers may include Thiamazol API manufacturers, exporters, distributors and traders.
click here to find a list of Thiamazol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Thiamazol Drug Master File in Japan (Thiamazol JDMF) empowers Thiamazol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Thiamazol JDMF during the approval evaluation for pharmaceutical products. At the time of Thiamazol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Thiamazol suppliers with JDMF on PharmaCompass.
LOOKING FOR A SUPPLIER?
